Pfizer to cut sales staff as meetings with healthcare providers go virtual

Pfizer will be reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people, Reuters news report said.

The move comes as the company is expected to announce more than $80 billion in revenue in 2021 on strong sales of the COVID-19 vaccine it developed with Germany’s BioNTech SE . That would be record sales for a pharmaceutical company, according to Pfizer Chief Executive Albert Bourla.